Skip to main content
Top
Published in: BMC Primary Care 1/2014

Open Access 01-12-2014 | Research article

Practice nurse involvement in primary care depression management: an observational cost-effectiveness analysis

Authors: Jodi Gray, Hossein Haji Ali Afzali, Justin Beilby, Christine Holton, David Banham, Jonathan Karnon

Published in: BMC Primary Care | Issue 1/2014

Login to get access

Abstract

Background

Most evidence on the effect of collaborative care for depression is derived in the selective environment of randomised controlled trials. In collaborative care, practice nurses may act as case managers. The Primary Care Services Improvement Project (PCSIP) aimed to assess the cost-effectiveness of alternative models of practice nurse involvement in a real world Australian setting. Previous analyses have demonstrated the value of high level practice nurse involvement in the management of diabetes and obesity. This paper reports on their value in the management of depression.

Methods

General practices were assigned to a low or high model of care based on observed levels of practice nurse involvement in clinical-based activities for the management of depression (i.e. percentage of depression patients seen, percentage of consultation time spent on clinical-based activities). Linked, routinely collected data was used to determine patient level depression outcomes (proportion of depression-free days) and health service usage costs. Standardised depression assessment tools were not routinely used, therefore a classification framework to determine the patient’s depressive state was developed using proxy measures (e.g. symptoms, medications, referrals, hospitalisations and suicide attempts). Regression analyses of costs and depression outcomes were conducted, using propensity weighting to control for potential confounders.

Results

Capacity to determine depressive state using the classification framework was dependent upon the level of detail provided in medical records. While antidepressant medication prescriptions were a strong indicator of depressive state, they could not be relied upon as the sole measure. Propensity score weighted analyses of total depression-related costs and depression outcomes, found that the high level model of care cost more (95% CI: -$314.76 to $584) and resulted in 5% less depression-free days (95% CI: -0.15 to 0.05), compared to the low level model. However, this result was highly uncertain, as shown by the confidence intervals.

Conclusions

Classification of patients’ depressive state was feasible, but time consuming, using the classification framework proposed. Further validation of the framework is required. Unlike the analyses of diabetes and obesity management, no significant differences in the proportion of depression-free days or health service costs were found between the alternative levels of practice nurse involvement.
Appendix
Available only for authorised users
Literature
1.
go back to reference Paykal ES, Brugha T, Fryers T: Size and burden of depressive disorders in Europe. Eur Neuropsychopharmacol. 2005, 15: 411-423. 10.1016/j.euroneuro.2005.04.008.CrossRef Paykal ES, Brugha T, Fryers T: Size and burden of depressive disorders in Europe. Eur Neuropsychopharmacol. 2005, 15: 411-423. 10.1016/j.euroneuro.2005.04.008.CrossRef
2.
go back to reference Australian Bureau of Statistics (ABS): National Survey of Mental Health and Wellbeing: Summary of results, Australia 2007. 2008, Canberra Australian Bureau of Statistics (ABS): National Survey of Mental Health and Wellbeing: Summary of results, Australia 2007. 2008, Canberra
4.
go back to reference Britt H, Miller GC, Charles J, Henderson J, Bayram C, Pan Y, Valenti L, Harrison C, O’Halloran J, Zhang C, et al: General practice activity in Australia 2010–11. 2011, Sydney: Sydney University Press Britt H, Miller GC, Charles J, Henderson J, Bayram C, Pan Y, Valenti L, Harrison C, O’Halloran J, Zhang C, et al: General practice activity in Australia 2010–11. 2011, Sydney: Sydney University Press
5.
go back to reference Bower P, Gilbody S, Richards D, Fletcher J, Sutton A: Collaborative care for depression in primary care. Making sense of a complex intervention: systematic review and meta-regression. Br J Psychiatry. 2006, 189: 484-493. 10.1192/bjp.bp.106.023655.CrossRefPubMed Bower P, Gilbody S, Richards D, Fletcher J, Sutton A: Collaborative care for depression in primary care. Making sense of a complex intervention: systematic review and meta-regression. Br J Psychiatry. 2006, 189: 484-493. 10.1192/bjp.bp.106.023655.CrossRefPubMed
6.
go back to reference Christensen H, Griffiths KM, Gulliver A, Clack D, Kljakovic M, Wells L: Models in the delivery of depression care: a systematic review of randomised and controlled intervention trials. BMC Fam Pract. 2008, 9: 25-10.1186/1471-2296-9-25.CrossRefPubMedPubMedCentral Christensen H, Griffiths KM, Gulliver A, Clack D, Kljakovic M, Wells L: Models in the delivery of depression care: a systematic review of randomised and controlled intervention trials. BMC Fam Pract. 2008, 9: 25-10.1186/1471-2296-9-25.CrossRefPubMedPubMedCentral
7.
go back to reference Thota AB, Sipe TA, Byard GJ, Zometa CS, Hahn RA, McKnight-Eily LR, Chapman DP, Abraido-Lanza AF, Pearson JL, Anderson CW, et al: Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysis. Am J Prev Med. 2012, 42 (5): 525-538. 10.1016/j.amepre.2012.01.019.CrossRefPubMed Thota AB, Sipe TA, Byard GJ, Zometa CS, Hahn RA, McKnight-Eily LR, Chapman DP, Abraido-Lanza AF, Pearson JL, Anderson CW, et al: Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysis. Am J Prev Med. 2012, 42 (5): 525-538. 10.1016/j.amepre.2012.01.019.CrossRefPubMed
8.
go back to reference Gilbody S, Bower P, Whitty P: Costs and consequences of enhanced primary care for depression: systematic review of randomised economic evaluations. Br J Psychiatry. 2006, 189: 297-308. 10.1192/bjp.bp.105.016006.CrossRefPubMed Gilbody S, Bower P, Whitty P: Costs and consequences of enhanced primary care for depression: systematic review of randomised economic evaluations. Br J Psychiatry. 2006, 189: 297-308. 10.1192/bjp.bp.105.016006.CrossRefPubMed
9.
go back to reference Jacob V, Chattopadhyay SK, Sipe TA, Thota AB, Byard GJ, Chapman DP: Economics of collaborative care for management of depressive disorders: a community guide systematic review. Am J Prev Med. 2012, 42 (5): 539-549. 10.1016/j.amepre.2012.01.011.CrossRefPubMed Jacob V, Chattopadhyay SK, Sipe TA, Thota AB, Byard GJ, Chapman DP: Economics of collaborative care for management of depressive disorders: a community guide systematic review. Am J Prev Med. 2012, 42 (5): 539-549. 10.1016/j.amepre.2012.01.011.CrossRefPubMed
11.
go back to reference Carne A, Moretti C, Smith B, Bywood P: Summary Data Report of the 2009–10 Annual Survey of Divisions of General Practice. 2011, Adelaide: Primary Health Care Research & Information Service, Discipline of General Practice, Flinders University, and Australian Government Department of Health and Ageing Carne A, Moretti C, Smith B, Bywood P: Summary Data Report of the 2009–10 Annual Survey of Divisions of General Practice. 2011, Adelaide: Primary Health Care Research & Information Service, Discipline of General Practice, Flinders University, and Australian Government Department of Health and Ageing
13.
go back to reference Keleher H, Joyce CM, Parker R, Piterman L: Practice nurses in Australia: current issues and future directions. Med J Aust. 2007, 187 (2): 108-110.PubMed Keleher H, Joyce CM, Parker R, Piterman L: Practice nurses in Australia: current issues and future directions. Med J Aust. 2007, 187 (2): 108-110.PubMed
14.
go back to reference Morgan M, Dunbar J, Reddy P, Coates M, Leahy R: The TrueBlue study: is practice nurse-led collaborative care effective in the management of depression for patients with heart disease or diabetes?. BMC Fam Pract. 2009, 10: 46-10.1186/1471-2296-10-46.CrossRefPubMedPubMedCentral Morgan M, Dunbar J, Reddy P, Coates M, Leahy R: The TrueBlue study: is practice nurse-led collaborative care effective in the management of depression for patients with heart disease or diabetes?. BMC Fam Pract. 2009, 10: 46-10.1186/1471-2296-10-46.CrossRefPubMedPubMedCentral
15.
go back to reference Morgan MA, Coates MJ, Dunbar JA, Reddy P, Schlicht K, Fuller J: The TrueBlue model of collaborative care using practice nurses as case managers for depression alongside diabetes or heart disease: a randomised trial. BMJ Open. 2013, 3 (1): 1-11.CrossRef Morgan MA, Coates MJ, Dunbar JA, Reddy P, Schlicht K, Fuller J: The TrueBlue model of collaborative care using practice nurses as case managers for depression alongside diabetes or heart disease: a randomised trial. BMJ Open. 2013, 3 (1): 1-11.CrossRef
16.
go back to reference Schlicht K, Morgan MA, Fuller J, Coates MJ, Dunbar JA: Safety and acceptability of practice-nurse-managed care of depression in patients with diabetes or heart disease in the Australian TrueBlue study. BMJ Open. 2013, 3 (4): 1-6.CrossRef Schlicht K, Morgan MA, Fuller J, Coates MJ, Dunbar JA: Safety and acceptability of practice-nurse-managed care of depression in patients with diabetes or heart disease in the Australian TrueBlue study. BMJ Open. 2013, 3 (4): 1-6.CrossRef
17.
go back to reference Stables RH: Observational research in the evidence based environment: eclipsed by the randomised controlled trial?. Heart. 2002, 87: 101-102. 10.1136/heart.87.2.101.CrossRefPubMedPubMedCentral Stables RH: Observational research in the evidence based environment: eclipsed by the randomised controlled trial?. Heart. 2002, 87: 101-102. 10.1136/heart.87.2.101.CrossRefPubMedPubMedCentral
18.
go back to reference Karnon J, Caffrey O, Pham C, Grieve R, Ben-Tovim D, Hakendorf P, Crotty M: Applying risk adjusted cost-effectiveness (RAC-E) analysis to hospitals: estimating the costs and consequences of variation in clinical practice. Health Econ. 2013, 22 (6): 631-42. 10.1002/hec.2828.CrossRefPubMed Karnon J, Caffrey O, Pham C, Grieve R, Ben-Tovim D, Hakendorf P, Crotty M: Applying risk adjusted cost-effectiveness (RAC-E) analysis to hospitals: estimating the costs and consequences of variation in clinical practice. Health Econ. 2013, 22 (6): 631-42. 10.1002/hec.2828.CrossRefPubMed
19.
go back to reference Haji Ali Afzali H, Gray J, Beilby J, Holton C, Banham D, Karnon J: A risk adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetes. Diabet Med. 2013, 30 (7): 855-63. 10.1111/dme.12195.CrossRefPubMed Haji Ali Afzali H, Gray J, Beilby J, Holton C, Banham D, Karnon J: A risk adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetes. Diabet Med. 2013, 30 (7): 855-63. 10.1111/dme.12195.CrossRefPubMed
20.
go back to reference Karnon J, Haji Ali Afzali H, Gray J: A risk adjusted cost-effectiveness analysis of alternative models of nurse involvement in obesity management in primary care. Obesity. 2013, 21 (3): 472-9. 10.1002/oby.20100.CrossRefPubMed Karnon J, Haji Ali Afzali H, Gray J: A risk adjusted cost-effectiveness analysis of alternative models of nurse involvement in obesity management in primary care. Obesity. 2013, 21 (3): 472-9. 10.1002/oby.20100.CrossRefPubMed
21.
go back to reference Nordstrom G, Despiegel N, Marteau F, Danchenko N, Maman K: Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden. J Med Econ. 2010, 13 (3): 516-526. 10.3111/13696998.2010.506371.CrossRefPubMed Nordstrom G, Despiegel N, Marteau F, Danchenko N, Maman K: Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden. J Med Econ. 2010, 13 (3): 516-526. 10.3111/13696998.2010.506371.CrossRefPubMed
22.
go back to reference Sicras-Mainar A, Navarro-Artieda R, Blanca-Tamayo M, Gimeno-de la Fuente V, Salvatella-Pasant J: Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences. Curr Med Res Opin. 2010, 26 (12): 2757-2764. 10.1185/03007995.2010.529430.CrossRefPubMed Sicras-Mainar A, Navarro-Artieda R, Blanca-Tamayo M, Gimeno-de la Fuente V, Salvatella-Pasant J: Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences. Curr Med Res Opin. 2010, 26 (12): 2757-2764. 10.1185/03007995.2010.529430.CrossRefPubMed
23.
go back to reference Haji Ali Afzali H, Karnon J, Gray J: A proposed model for economic evaluations of major depressive disorder. Eur J Health Econ. 2012, 13 (4): 501-510. 10.1007/s10198-011-0321-3.CrossRefPubMed Haji Ali Afzali H, Karnon J, Gray J: A proposed model for economic evaluations of major depressive disorder. Eur J Health Econ. 2012, 13 (4): 501-510. 10.1007/s10198-011-0321-3.CrossRefPubMed
24.
go back to reference Haji Ali Afzali H, Karnon J, Gray J, Beilby J: Evaluation of collaborative models of care in management of patients with depression - protocol and progress. Ment Health Fam Med. 2012, 9 (2): 91-97. Haji Ali Afzali H, Karnon J, Gray J, Beilby J: Evaluation of collaborative models of care in management of patients with depression - protocol and progress. Ment Health Fam Med. 2012, 9 (2): 91-97.
26.
go back to reference Howell CA: PhD thesis. Study of a primary care depression relapse prevention program: “Keeping the blues away”. 2009, Adelaide: University of Adelaide, Discipline of General Practice Howell CA: PhD thesis. Study of a primary care depression relapse prevention program: “Keeping the blues away”. 2009, Adelaide: University of Adelaide, Discipline of General Practice
27.
go back to reference Guo S, Fraser MW: Propensity score analysis: Statistical methods and application. 2010, California: Sage Publications Guo S, Fraser MW: Propensity score analysis: Statistical methods and application. 2010, California: Sage Publications
30.
go back to reference Glick HA, Doshi JA, Sonnad SS, Polsky D: Economic Evaluation in Clinical Trials. 2007, Oxford: Oxford University Press Glick HA, Doshi JA, Sonnad SS, Polsky D: Economic Evaluation in Clinical Trials. 2007, Oxford: Oxford University Press
31.
go back to reference Austin P: An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011, 46 (3): 399-424. 10.1080/00273171.2011.568786.CrossRefPubMedPubMedCentral Austin P: An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011, 46 (3): 399-424. 10.1080/00273171.2011.568786.CrossRefPubMedPubMedCentral
32.
go back to reference Henderson J, Harrison C, Britt H: Indications for antidepressant medication use in Australian general practice patients [letter]. Aust N Z J Psychiatry. 2010, 44 (9): 865-CrossRefPubMed Henderson J, Harrison C, Britt H: Indications for antidepressant medication use in Australian general practice patients [letter]. Aust N Z J Psychiatry. 2010, 44 (9): 865-CrossRefPubMed
33.
go back to reference Sobocki P, Ekman M, Ovanfors A, Khandker R, Jonsson B: The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder. Int J Clin Pract. 2008, 62 (4): 623-632. 10.1111/j.1742-1241.2008.01711.x.CrossRefPubMedPubMedCentral Sobocki P, Ekman M, Ovanfors A, Khandker R, Jonsson B: The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder. Int J Clin Pract. 2008, 62 (4): 623-632. 10.1111/j.1742-1241.2008.01711.x.CrossRefPubMedPubMedCentral
34.
go back to reference Sullivan P: A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. CNS Drugs. 2004, 18 (13): 911-932. 10.2165/00023210-200418130-00006.CrossRefPubMed Sullivan P: A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. CNS Drugs. 2004, 18 (13): 911-932. 10.2165/00023210-200418130-00006.CrossRefPubMed
35.
go back to reference Unützer J, Katon W, Williams JW, Callahan CM, Harpole L, Hunkeler EM, Hoffing M, Arean P, Hegel MT, Schoenbaum M, et al: Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care. 2001, 39 (8): 785-799. 10.1097/00005650-200108000-00005.CrossRefPubMed Unützer J, Katon W, Williams JW, Callahan CM, Harpole L, Hunkeler EM, Hoffing M, Arean P, Hegel MT, Schoenbaum M, et al: Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care. 2001, 39 (8): 785-799. 10.1097/00005650-200108000-00005.CrossRefPubMed
37.
go back to reference Healthcare Management Advisors Pty Ltd (HMA), Department of Health and Ageing (DoHA): Evaluation of the mental health nurse incentive program, final report. 2012, Adelaide: HMA Healthcare Management Advisors Pty Ltd (HMA), Department of Health and Ageing (DoHA): Evaluation of the mental health nurse incentive program, final report. 2012, Adelaide: HMA
Metadata
Title
Practice nurse involvement in primary care depression management: an observational cost-effectiveness analysis
Authors
Jodi Gray
Hossein Haji Ali Afzali
Justin Beilby
Christine Holton
David Banham
Jonathan Karnon
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2014
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/1471-2296-15-10

Other articles of this Issue 1/2014

BMC Primary Care 1/2014 Go to the issue